Eskazine

Known as: SmithKline Beecham Brand of Trifluoperazine Hydrochloride 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2017
0246819852017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Professor Sian Harding talks to Caroline Telfer, Assistant Commissioning Editor. Professor Sian Harding obtained her PhD in… (More)
Is this relevant?
2009
2009
Molecular Enzymology Group Colloquium Organized by D. Fell (School of Biological and Molecular Sciences, Oxford Brooke University… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 8
Is this relevant?
2002
2002
The problem of Loa-encephalopathy, which may occur after ivermectin treatment of patients harbouring high Loa microfilarial loads… (More)
Is this relevant?
2002
2002
Prof. Dr. med. Klaus-Michael Debatin (Abb. 1) ist in Karlsruhe geboren und 49 Jahre alt. Er hat in Ulm, Freiburg und Heidelberg… (More)
Is this relevant?
2001
2001
SmithKline Beecham is developing the 5-HT6 antagonist, SB-271046, as a potential cognition enhancer. By December 1999, phase I… (More)
Is this relevant?
2001
2001
Morphine mimics the cardioprotective effect of ischemic preconditioning (PC) through a mechanism sensitive to glibenclamide and… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND The mitogen-activated protein (MAP) kinases are important signaling molecules that participate in diverse cellular… (More)
Is this relevant?
1998
1998
  • S S Hedge
  • IDrugs : the investigational drugs journal
  • 1998
Epristeride is a transition-state, noncompetitive steroid 5-alpha-reductase inhibitor under development by SmithKline Beecham for… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Thiazolidinediones offer promise as oral insulin-sensitizing agents. The effects of a new, high-potency compound (BRL 49653… (More)
Is this relevant?
1992
1992
The rationale for the development of a Repertory-Grid based quality of life assessment (QOL) is described. The emergent scale… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?